RNS Number : 1806O
UPL Limited
13 May 2024
 

UPL LIMITED

  

 

Sub: 

1.   Audited Standalone and Consolidated Financial Results for the quarter and financial year ended 31st March 2024 and recommendation of dividend.

2.   Press Release.

3.   Investor Presentation.

 

Dear Sir/Madam,

 

The Board of Directors of the Company ("Board") held today i.e. Monday, 13th May 2024, has considered and approved the audited standalone and consolidated financial results of the Company for the quarter and financial year ended 31st March 2024.  

The Board has recommended a dividend of 50% i.e. Rs. 1/- per equity share on equity shares of Rs. 2/-each, subject to approval of members at the ensuing Annual General Meeting.

The links for Financial results, Press Release and Investor Presentation is mentioned below:-

 

Links:

 

1.   Financials: -

 

https://www.bseindia.com/xml-data/corpfiling/AttachLive/07dfaeda-90fc-4abf-9ad5-9e486343b528.pdf

 

2.   Press Release:-

 

https://www.bseindia.com/xml-data/corpfiling/AttachLive/8e040859-fc76-4fc4-abb3-9df3a6dc3f85.pdf

 

 

3.   Investor Presentation:-

 

https://www.bseindia.com/xml-data/corpfiling/AttachLive/7787d180-84ec-4ab9-94ed-b7a0c0d7bad1.pdf

 

We request you to take note of the same.

 

Thanking you,

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
CIRUORRRSBUVAAR